Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
01/2006
01/03/2006CA2156289C Drug composition containing nucleic acid copolymer
01/03/2006CA2153572C Transdermal therapeutic system with galanthamine as active ingredient
01/03/2006CA2138974C Dermatological agent for aiding oxygen transport in the skin
12/2005
12/30/2005CA2510985A1 Pharmaceutical formulations for the safe administration of drugs used in the treatment of drug addiction and processes for obtaining the same
12/29/2005WO2005123907A2 Ex-vivo application of solid microparticulate therapeutic agents
12/29/2005WO2005123239A1 Method of growing crystals
12/29/2005WO2005123172A1 Device for targeted delivery of medicinal, cosmetic, and related agents
12/29/2005WO2005123151A2 Device for releasing an active ingredient and piece of jewelry embodied to give off a scent
12/29/2005WO2005123150A1 Polymeric compositions for sustained release of volatile materials
12/29/2005WO2005123138A1 Pharmaceutical pellet compositions for controlled release
12/29/2005WO2005123136A1 Antiinflammatory and analgesic preparation for external use
12/29/2005WO2005123135A1 Stabilized compositions comprising a therapeutically active agent, citric acid or a conjugated base and chlorine dioxide
12/29/2005WO2005123134A2 A controlled release delivery system for metformin
12/29/2005WO2005123133A1 A process for preparing ibuprofen soft gelatin capsules
12/29/2005WO2005123131A2 High pressure spray-dry of bioactive materials
12/29/2005WO2005123114A2 Silk-based drug delivery system
12/29/2005WO2005123103A1 Topical compositions and methods for epithelial-related conditions
12/29/2005WO2005123092A1 Composition for the treatment of psoriasis comprising a silicone agent, a corticosteroid and vitamin d or a derivative thereof
12/29/2005WO2005123091A1 Composition in the form of a spray comprising a combination of clobetasol propionate and calcitriol, an alcohol phase and an oily phase
12/29/2005WO2005123090A1 Composition in spray form comprising a combination of a corticoid and a vitamin d derivative in an oily phase
12/29/2005WO2005123088A1 Solid orally ingestible formulations of tetrodotoxin
12/29/2005WO2005123086A2 Ziprasidone dosage form
12/29/2005WO2005123085A1 Orally-administered aqueous risperidone solution
12/29/2005WO2005123084A1 Orally disintegrating pharmaceutical composition comprising risperidone
12/29/2005WO2005123078A1 Liposome preparation containing slightly water-soluble camptothecin
12/29/2005WO2005123076A2 Pharmaceutical compositions
12/29/2005WO2005123064A1 Adrenergic complement inhaler comprising compounds such as ascorbates tocopherols or polycaboxylic acid chelators
12/29/2005WO2005123061A1 Pharmaceutical compositions containing polyunsaturated fatty acid and at least one of an immunosuppressive agent or an antineoplastic agent
12/29/2005WO2005123053A2 Use of cb2 receptors agonists for the treatment of huntington’s disease
12/29/2005WO2005123047A2 Methods of managing multi-tissue injuries
12/29/2005WO2005123046A1 Novel transdermal preparation and its producing method
12/29/2005WO2005123045A2 Controlled release matrix pharmaceutical dosage formulation
12/29/2005WO2005123044A2 Implantable device for treating disease states and methods of using same
12/29/2005WO2005123043A2 Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same
12/29/2005WO2005123042A1 Controlled release pharmaceutical formulation
12/29/2005WO2005123041A1 Oral dispersible tablet composition of amoxycillin and/or clavulanic acid comprising a surface-modified sodium bicarbonate
12/29/2005WO2005123040A1 Tablet rapidly disintegrating in mouth
12/29/2005WO2005123039A1 Abuse-deterrent drug formulations
12/29/2005WO2005123038A1 Enhanced medical product
12/29/2005WO2005123037A1 Triterpene-containing oleogel-forming agent, triterpene-containing oleogel and method for producing a triterpene-containing oleogel
12/29/2005WO2005123036A1 Methods to control termites
12/29/2005WO2005123035A1 Hydrophobic ophthalmic compositions and methods of use
12/29/2005WO2005123034A2 Microparticulate systems for the oral administration of biologically active substances
12/29/2005WO2005123033A2 Fine particles of cilostazol and processes for production thereof
12/29/2005WO2005123024A1 Tooth whitening products and methods of making the same
12/29/2005WO2005123004A1 Minimizing powder retention on surfaces
12/29/2005WO2005123002A1 Inhaler using pods
12/29/2005WO2005122734A2 Nanosphere/microsphere delivery system for the treatment of spinal cord injury
12/29/2005WO2005122729A2 An iron sequestering antimicrobial composition
12/29/2005WO2005107765A3 Heart treatment method
12/29/2005WO2005107753A3 Naltrexone long acting formulations and methods of use
12/29/2005WO2005096717A3 Agent exhibiting hepatoprotective properties
12/29/2005WO2005091872A3 Pharmaceutical composition and method for the transdermal delivery of magnesium
12/29/2005WO2005072343A3 Aqueous pharmaceutical compositions 2,6-diisopropylphenol (propofol) and their use
12/29/2005WO2005065121A3 Methods and compositions for the production of monoclonal antibodies
12/29/2005WO2005060981A3 Pharmaceutical compositions
12/29/2005WO2005060939A3 Controlled-release pharmaceutical formulation
12/29/2005WO2005058242A3 Chewable soft capsules containing ungelatinized starch
12/29/2005WO2005040353A3 Immunogenic compostion and method of developing a vaccine based on psoralen inactivated hiv
12/29/2005WO2005040352A3 Immunogenic composition and method of developing a vaccine based on factor h binding sites
12/29/2005WO2005037256B1 Liquid preparation containing tobramycin
12/29/2005WO2005035733A3 Modified whole cell, cell extract and omv-based vaccines
12/29/2005WO2005016558A3 Methods for accelerated release of material from a reservoir device
12/29/2005WO2005016273A3 Infection prophylaxis using immune response modifier compounds
12/29/2005WO2005011618A3 Methods for the treatment of male and female sexual dysfunction
12/29/2005WO2005001008A3 Fragrance sampler insert
12/29/2005WO2004100872A3 Liquid aerosol formulations containing insulin and aerosol generating devices and methods for generating aerosolized insulin
12/29/2005WO2004085998A3 Biomimetic hierarchies using functionalized nanoparticles as building blocks
12/29/2005WO2004073658A3 Isoflavone derivatives
12/29/2005US20050288789 Spinal disc nucleus pulposus implant
12/29/2005US20050288374 Chemical stabilization of solubilized retinoids and aqueous compositions comprised thereof
12/29/2005US20050288315 4-((7-chloroquinolin-4-yl)aminoalkyleneamino-)-spiro(cyclohexane-1.5'-1H-4,5,6-trioxaindene )dicitrate; malaria; paraciticides; antiprotozoa agents; Plasmodium; synergistic; chloroquine-resistant; cost efficiency; industrial scale; penetration and activity of artemisine
12/29/2005US20050288292 Pharmaceutical formulation and its use in the treatment of inner ear diseases
12/29/2005US20050288276 Pharmaceutical formulation of olanzapine
12/29/2005US20050288274 Treating rhinitis by topically administering an epinastine solution to the nasal mucous membrane
12/29/2005US20050288261 Compositions and method for treating infection in cattle and swine
12/29/2005US20050288259 Composition
12/29/2005US20050288235 Sodium chloride; dextran, carboxymethyl starch, sodium alginate, pentahydroxyethyl starch, gelatin derivatives or pectin; NaHCO3, KCl, MgSO4, CaCl, calcium gluconate, calcium lactate, sodium lactate, and/or Tris buffer; total Na ion does not exceed equivalent concentration of 6.9% (w/v); traumatic shock
12/29/2005US20050288232 As prodrug of enalaprilat, which is a medicine useful for preventing or treating circulatory diseases such as hypertension, cardiac diseases, nephritis, and apoplexy, patches; 1-[N-[(1S)-1-Carboxy-3-phenylpropyl]-L-alanyl]-L-proline 2-hydroxyethyl ester
12/29/2005US20050288197 Silicone polymer topical eye compositions and methods of use
12/29/2005US20050288196 Silicone polymer contact lens compositions and methods of use
12/29/2005US20050287325 Pharmaceutical containers with low adsorption/absorption of active ingredients, and a method of testing materials for adsorption/absorption of active ingredients
12/29/2005US20050287320 Method of producing structures using centrifugal forces
12/29/2005US20050287221 Method and apparatus for encapsulating pharmaceutical and nutriceutical bioactives for intestinal delivery
12/29/2005US20050287220 solvent selected from glycerol formal, ethyl lactate, and hydroxypropyl methylcellulose; antibacterial agent, antifungal agent, antiparasitic agent, antiyeast agent, antiviral agent, antiinflammatory agent; gel for controlled or sustained release; infection of the skin, ear, or eye; veterinary medicine
12/29/2005US20050287219 Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
12/29/2005US20050287218 Biomaterial
12/29/2005US20050287217 Transdermal delivery system for water insoluble drugs
12/29/2005US20050287216 Medical imaging agents for injectable compositions
12/29/2005US20050287215 Hemostatic compositions and devices
12/29/2005US20050287214 Squeeze controlled oral dosage form
12/29/2005US20050287213 Dosage forms for low solubility and or low dissolution rate free acid pharmaceutical agents
12/29/2005US20050287212 Oral delivery system comprising a drug/polymer complex
12/29/2005US20050287211 Oral pharmaceutical compositions in timed-release particle form and fast-disintegrating tablets containing this composition
12/29/2005US20050287210 Also including 0.5-5 % polyvinylpyrrolidone and 5-40 % hydroxypropyl methylcellulose; administering an endothelial nitric oxide synthase agonist (an HMG-CoA reductase inhibitor) and a NO precursor (L-arginine hydrochloride) for cerebrovascular/cardiovascular disorders; anticholesterol agents
12/29/2005US20050287209 Directly compressible formulations of azithromycin
12/29/2005US20050287208 Cross-linked powered/microfibrillated cellulose II
12/29/2005US20050287207 Solid preparation
12/29/2005US20050287206 Solubilized CoQ-10 and carnitine
12/29/2005US20050287205 Dietary supplement compositions
1 ... 1704 1705 1706 1707 1708 1709 1710 1711 1712 1713 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 ... 2991